Media ReleasesImmutep

View All Immutep News


Immutep Announces Presentation at Oppenheimer’s 29th Annual Healthcare Conference

SYDNEY, AUSTRALIA – 04 March 2019 - Immutep Limited (ASX:IMM; NASDAQ:IMMP) (Immutep or the Company), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, today announced its participation in Oppenheimer’s 29th Annual Healthcare Conference.

Marc Voigt, CEO of Immutep, is scheduled to present a corporate overview and business update.

Conference: Oppenheimer’s 29th Annual Healthcare Conference

Dates: 19 March 2019, from 9:10 AM to 9:40 AM Eastern Standard Time

Venue: The Westin New York Grand Central, 212 East 42nd Street, New York, USA

Presenter: Marc Voigt, CEO of Immutep

The presentation is expected to be live webcasted. A link to the webcast will be made available on the Company’s website.


For further information please download PDF attached:
Download this document